Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Chuikyo Members Divided on Usage of Savings from NHI Price Cuts
January 26, 2015
- 3-Price Bracket Rule for Generics Causing Various Distortions, Problems: JGA President
January 23, 2015
- Ihoken Proposes New Pricing Rule for Regenerative Medicines
January 22, 2015
- Some LDP Members Keen to Tackle Kampo NHI Price Problem
January 21, 2015
- JSMI to Announce in May a “Grand Design” for OTC Drug Industry
January 21, 2015
- JPMA Notifies of Unfavorable Expressions for Disease Awareness Ads
January 16, 2015
- Pharma Leader Nakayama Hails Tax Plan, Says His New Year Remarks Misleading
January 15, 2015
- Wholesalers Must Revamp Biz Model to Cope with Change in Sales Mix: JPWA Chief
January 14, 2015
- Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President
January 9, 2015
- Pharma Biz Leader Airs Concern over Effective Tax Hikes
January 8, 2015
- Sumitomo Dainippon President Praises Govt’s Healthcare Measures
January 6, 2015
- FPMAJ Chairman Wishes for Good Environment for Drug Innovation in 2015
January 1, 2015
- FPMAJ “Hasn’t Given Up” on Maintenance of 30% R&D Tax Deduction Cap: Chairman
December 24, 2014
- EFPIA Japan Chairman Calls for More Rewards for Innovation
December 22, 2014
- Bristol-Myers Reprimanded by JPMA over Misconduct in Sprycel Trial
December 19, 2014
- JPMA to Formulate Strict Official Policy on Advertising Aimed at Medical Institutions by End of Fiscal Year
December 19, 2014
- JMA Chief Lauds Big Win by LDP, Komeito in Lower House Race
December 17, 2014
- JPMA to Require Disclosure of Clinical R&D Costs in More Detail
December 15, 2014
- JMA, JAMS Call for Enhancing Support for Girls Suffering from Post-HPV Vaccine Reactions
December 12, 2014
- JPMA President Opposes Annual NHI Price Revision
November 21, 2014
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…